筛选出 50 条数据

    品牌 产品 货期 价格 货号 规格 /
    G蛋白偶联受体&G蛋白174636-32-9

    CAS号:174636-32-9

    品名:(-)-(S)-N-(alpha-乙基苄基)-3-羟基-2-苯基喹啉-4-羧酰胺3-hydroxy-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide

    中文别名:(-)-(S)-N-(alpha-乙基苄基)-3-羟基-2-苯基喹啉-4-羧酰胺

    英文别名:Talnetant;(S)-N-(1-Phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide,SB-223412;UNII-CZ3T9T146K;

    分子式:C25H22N2O2

    分子量:382.454

    精确质量:382.168

    Psa:65.71

    UNII号:CZ3T9T146K

    密度:1.212g/cm3

    沸点:580.4ºC at 760mmHg

    闪点:304.8ºC

    折射率:1.657

    蒸汽压:4.51E-14mmHg at 25°C

    简介:Talnetant(SB-223,412)isaneurokinin3receptorantagonistdevelopedbyGlaxoSmithKline,whichisbeingresearchedforseveraldifferentfunctions,primarilyforirritablebowelsyndromehoweveritsuseasapotentialantipsychoticdrugforthetreatmentofschizophreniahasbeendiscontinued.

     174636-32-9 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:174636-32-9

    品名:(-)-(S)-N-(alpha-乙基苄基)-3-羟基-2-苯基喹啉-4-羧酰胺3-hydroxy-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide

    中文别名:(-)-(S)-N-(alpha-乙基苄基)-3-羟基-2-苯基喹啉-4-羧酰胺

    英文别名:Talnetant;(S)-N-(1-Phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide,SB-223412;UNII-CZ3T9T146K;

    分子式:C25H22N2O2

    分子量:382.454

    精确质量:382.168

    Psa:65.71

    UNII号:CZ3T9T146K

    密度:1.212g/cm3

    沸点:580.4ºC at 760mmHg

    闪点:304.8ºC

    折射率:1.657

    蒸汽压:4.51E-14mmHg at 25°C

    简介:Talnetant(SB-223,412)isaneurokinin3receptorantagonistdevelopedbyGlaxoSmithKline,whichisbeingresearchedforseveraldifferentfunctions,primarilyforirritablebowelsyndromehoweveritsuseasapotentialantipsychoticdrugforthetreatmentofschizophreniahasbeendiscontinued.

    展开

    G蛋白偶联受体&G蛋白174636-32-9
    阿拉丁 他尔奈坦 Talnetant 现货

     6797.90
    T125777 Moligand™,≥98%
    TargetMol 化合物Talnetant Talnetant 现货

     6130.00
    T7549 ≥95%
    G蛋白偶联受体&G蛋白215803-78-4

    CAS号:215803-78-4

    品名:N-((1r,4r)-4-(2-(6-氰基-3,4-二氢异喹啉-2(1h)-基)乙基)环己基)喹啉-4-羧酰胺N-[4-[2-(6-cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]quinoline-4-carboxamide

    中文别名:N-((1r,4r)-4-(2-(6-氰基-3,4-二氢异喹啉-2(1h)-基)乙基)环己基)喹啉-4-羧酰胺

    英文别名:N-((1r,4r)-4-(2-(6-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)quinoline-4-carboxamide;

    分子式:C28H30N4O

    分子量:438.564

    精确质量:438.242

    Psa:69.02

    密度:1.23g/cm3

    沸点:679.3ºC at 760 mmHg

    闪点:364.6ºC

    折射率:1.656

    蒸汽压:2.61E-18mmHg at 25°C

     215803-78-4 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:215803-78-4

    品名:N-((1r,4r)-4-(2-(6-氰基-3,4-二氢异喹啉-2(1h)-基)乙基)环己基)喹啉-4-羧酰胺N-[4-[2-(6-cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]quinoline-4-carboxamide

    中文别名:N-((1r,4r)-4-(2-(6-氰基-3,4-二氢异喹啉-2(1h)-基)乙基)环己基)喹啉-4-羧酰胺

    英文别名:N-((1r,4r)-4-(2-(6-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)quinoline-4-carboxamide;

    分子式:C28H30N4O

    分子量:438.564

    精确质量:438.242

    Psa:69.02

    密度:1.23g/cm3

    沸点:679.3ºC at 760 mmHg

    闪点:364.6ºC

    折射率:1.656

    蒸汽压:2.61E-18mmHg at 25°C

    展开

    G蛋白偶联受体&G蛋白215803-78-4
    源叶 SB-277011 SB-277011 现货

     5898.00
    Y31122 /
    阿拉丁 SB-277011,多巴胺D3受体拮抗剂 SB-277011 期货,请咨询

     5091.90
    S125423 Moligand™
    G蛋白偶联受体&G蛋白312636-16-1

    CAS号:312636-16-1

    品名:4-[[4-(4-氯苯基)-2-噻唑基]氨基]苯酚4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenol

    中文别名:4-[[4-(4-氯苯基)-2-噻唑]氨基]苯酚;鞘氨醇激酶抑制剂;

    英文别名:4-[[4-(4-Chlorophenyl)-2-thiazolyl]amino]phenol;UUL;Phenol(4-[[4-(4-chlorophenyl)-2-thiazolyl]amino];SKIII;Kinome_2076;SphK-I2,SphingosineKinaseInhibitor2;

    分子式:C15H11ClN2OS

    分子量:302.779

    精确质量:302.028

    Psa:73.39

    密度:1.415g/cm3

    沸点:507.1ºC at 760mmHg

    闪点:260.5ºC

    折射率:1.709

    储存条件:2-8ºC

    简介:SKIIIisanonlipidinhibitorofsphingosinekinase.SKIIIsorallybioavailableandhasshownsignificantinhibitionoftumorgrowthinmice.

     312636-16-1 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:312636-16-1

    品名:4-[[4-(4-氯苯基)-2-噻唑基]氨基]苯酚4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenol

    中文别名:4-[[4-(4-氯苯基)-2-噻唑]氨基]苯酚;鞘氨醇激酶抑制剂;

    英文别名:4-[[4-(4-Chlorophenyl)-2-thiazolyl]amino]phenol;UUL;Phenol(4-[[4-(4-chlorophenyl)-2-thiazolyl]amino];SKIII;Kinome_2076;SphK-I2,SphingosineKinaseInhibitor2;

    分子式:C15H11ClN2OS

    分子量:302.779

    精确质量:302.028

    Psa:73.39

    密度:1.415g/cm3

    沸点:507.1ºC at 760mmHg

    闪点:260.5ºC

    折射率:1.709

    储存条件:2-8ºC

    简介:SKIIIisanonlipidinhibitorofsphingosinekinase.SKIIIsorallybioavailableandhasshownsignificantinhibitionoftumorgrowthinmice.

    展开

    G蛋白偶联受体&G蛋白312636-16-1
    毕得 4-((4-(4-氯苯基)噻唑-2-基)氨基)苯酚 4-((4-(4-Chlorophenyl)thiazo... 无货,请咨询

     5860.00
    BD6408 98%
    Echelon 鞘氨醇激酶抑制剂 SphingosineKinaseInhibitor... 49天

     7645.00
    B-0024 /
    G蛋白偶联受体&G蛋白1000413-72-8

    CAS号:1000413-72-8

    品名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]aceticacid

    中文别名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸

    英文别名:Fasiglifam(INN);Fasiglifam;3-Benzofuranaceticacid,6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-,(3S);TAK-875;((3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl)aceticacid;

    分子式:C29H32O7S

    分子量:524.625

    精确质量:524.187

    Psa:107.51

    MDL号:MFCD18251445

    密度:1.3±0.1g/cm3

    沸点:739.1±60.0°Cat760mmHg

    闪点:400.8±32.9°C

    折射率:1.587

    储存条件:2-8℃

    蒸汽压:0.0±2.6mmHgat25°C

    简介:TAK-876isaselectiveGprotein-coupledreceptor40(GPR40)agonist.TAK-876isanoveloralmedicationthathasbeendevelopedtoimprovethesecretionofinsulininaglucose-dependentmanner,whichhasthepotentialtoimprovethecontrolofbloodsugarlevelswithouttheriskofhypoglycemia.

     1000413-72-8 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:1000413-72-8

    品名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]aceticacid

    中文别名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸

    英文别名:Fasiglifam(INN);Fasiglifam;3-Benzofuranaceticacid,6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-,(3S);TAK-875;((3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl)aceticacid;

    分子式:C29H32O7S

    分子量:524.625

    精确质量:524.187

    Psa:107.51

    MDL号:MFCD18251445

    密度:1.3±0.1g/cm3

    沸点:739.1±60.0°Cat760mmHg

    闪点:400.8±32.9°C

    折射率:1.587

    储存条件:2-8℃

    蒸汽压:0.0±2.6mmHgat25°C

    简介:TAK-876isaselectiveGprotein-coupledreceptor40(GPR40)agonist.TAK-876isanoveloralmedicationthathasbeendevelopedtoimprovethesecretionofinsulininaglucose-dependentmanner,whichhasthepotentialtoimprovethecontrolofbloodsugarlevelswithouttheriskofhypoglycemia.

    展开

    G蛋白偶联受体&G蛋白1000413-72-8
    Am Fasiglifam Fasiglifam 现货

     6750.00
    A690887 98%
    阿拉丁 TAK-875 TAK-875 现货

     7675.90
    T127963 Moligand™,≥98%
    G蛋白偶联受体&G蛋白222551-17-9

    CAS号:1000413-72-8

    品名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]aceticacid

    中文别名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸

    英文别名:Fasiglifam(INN);Fasiglifam;3-Benzofuranaceticacid,6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-,(3S);TAK-875;((3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl)aceticacid;

    分子式:C29H32O7S

    分子量:524.625

    精确质量:524.187

    Psa:107.51

    MDL号:MFCD18251445

    密度:1.3±0.1g/cm3

    沸点:739.1±60.0°Cat760mmHg

    闪点:400.8±32.9°C

    折射率:1.587

    储存条件:2-8℃

    蒸汽压:0.0±2.6mmHgat25°C

    简介:TAK-876isaselectiveGprotein-coupledreceptor40(GPR40)agonist.TAK-876isanoveloralmedicationthathasbeendevelopedtoimprovethesecretionofinsulininaglucose-dependentmanner,whichhasthepotentialtoimprovethecontrolofbloodsugarlevelswithouttheriskofhypoglycemia.

     222551-17-9 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:1000413-72-8

    品名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]aceticacid

    中文别名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸

    英文别名:Fasiglifam(INN);Fasiglifam;3-Benzofuranaceticacid,6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-,(3S);TAK-875;((3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl)aceticacid;

    分子式:C29H32O7S

    分子量:524.625

    精确质量:524.187

    Psa:107.51

    MDL号:MFCD18251445

    密度:1.3±0.1g/cm3

    沸点:739.1±60.0°Cat760mmHg

    闪点:400.8±32.9°C

    折射率:1.587

    储存条件:2-8℃

    蒸汽压:0.0±2.6mmHgat25°C

    简介:TAK-876isaselectiveGprotein-coupledreceptor40(GPR40)agonist.TAK-876isanoveloralmedicationthathasbeendevelopedtoimprovethesecretionofinsulininaglucose-dependentmanner,whichhasthepotentialtoimprovethecontrolofbloodsugarlevelswithouttheriskofhypoglycemia.

    展开

    G蛋白偶联受体&G蛋白222551-17-9
    TargetMol 阿哆嗪 Adoprazine 现货

     6910.00
    T10249 99.44%
    G蛋白偶联受体&G蛋白173937-91-2

    CAS号:173937-91-2

    品名:阿曲生坦atrasentan

    中文别名:(2R,3R,4S)-4-(1,3-苯并二氧戊环-5-基)-1-[2-(二丁基氨基)-2-氧代乙基]-2-(4-甲氧基苯基)吡咯烷-3-羧酸;

    英文别名:[2R,3R,4S]-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-[[(N,N-dibutylamino)-carboxyl]methyl]pyrrolidine-3-carboxylicacid;(2R,3R,4S)-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((N,N-dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylicacid;(2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylicacid;(2R,3R,4S)-(+)-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylicacid;

    分子式:C29H38N2O6

    分子量:510.622

    精确质量:510.273

    Psa:88.54

    UNII号:V6D7VK2215

    密度:1.188g/cm3

    沸点:659.4ºC at 760mmHg

    闪点:352.6ºC

    蒸汽压:2.76E-18mmHg at 25°C

    简介:Atrasentanisanexperimentaldrugthatisbeingstudiedforthetreatmentofvarioustypesofcancer,includingnon-smallcelllungcancer.Itisalsobeinginvestigatedasatherapyfordiabetickidneydisease.

     173937-91-2 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:173937-91-2

    品名:阿曲生坦atrasentan

    中文别名:(2R,3R,4S)-4-(1,3-苯并二氧戊环-5-基)-1-[2-(二丁基氨基)-2-氧代乙基]-2-(4-甲氧基苯基)吡咯烷-3-羧酸;

    英文别名:[2R,3R,4S]-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-[[(N,N-dibutylamino)-carboxyl]methyl]pyrrolidine-3-carboxylicacid;(2R,3R,4S)-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((N,N-dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylicacid;(2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylicacid;(2R,3R,4S)-(+)-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylicacid;

    分子式:C29H38N2O6

    分子量:510.622

    精确质量:510.273

    Psa:88.54

    UNII号:V6D7VK2215

    密度:1.188g/cm3

    沸点:659.4ºC at 760mmHg

    闪点:352.6ºC

    蒸汽压:2.76E-18mmHg at 25°C

    简介:Atrasentanisanexperimentaldrugthatisbeingstudiedforthetreatmentofvarioustypesofcancer,includingnon-smallcelllungcancer.Itisalsobeinginvestigatedasatherapyfordiabetickidneydisease.

    展开

    G蛋白偶联受体&G蛋白173937-91-2
    TargetMol 阿曲生坦 Atrasentan 期货,请咨询

     5790.00
    TQ0259 99.08%
    G蛋白偶联受体&G蛋白1415562-82-1

    CAS号:1415562-82-1

    品名:(2R)-1-[[4-[[3-甲基-5-[(苯磺酰基)甲基]苯氧基]甲基]苯基]甲基]-2-吡咯烷甲醇[(2R)-1-[[4-[[3-(benzenesulfonylmethyl)-5-methylphenoxy]methyl]phenyl]methyl]pyrrolidin-2-yl]methanol

    中文别名:(2R)-1-[[4-[[3-甲基-5-[(苯磺酰基)甲基]苯氧基]甲基]苯基]甲基]-2-吡咯烷甲醇

    英文别名:PF543;CS-0869;PF-543||PF543;

    分子式:C27H31NO4S

    分子量:465.604

    精确质量:465.197

    Psa:75.22

    密度:1.2±0.1g/cm3

    沸点:666.0±55.0°Cat760mmHg

    闪点:356.6±31.5°C

    折射率:1.610

    储存条件:-20℃

    蒸汽压:0.0±2.1mmHgat25°C

     1415562-82-1 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:1415562-82-1

    品名:(2R)-1-[[4-[[3-甲基-5-[(苯磺酰基)甲基]苯氧基]甲基]苯基]甲基]-2-吡咯烷甲醇[(2R)-1-[[4-[[3-(benzenesulfonylmethyl)-5-methylphenoxy]methyl]phenyl]methyl]pyrrolidin-2-yl]methanol

    中文别名:(2R)-1-[[4-[[3-甲基-5-[(苯磺酰基)甲基]苯氧基]甲基]苯基]甲基]-2-吡咯烷甲醇

    英文别名:PF543;CS-0869;PF-543||PF543;

    分子式:C27H31NO4S

    分子量:465.604

    精确质量:465.197

    Psa:75.22

    密度:1.2±0.1g/cm3

    沸点:666.0±55.0°Cat760mmHg

    闪点:356.6±31.5°C

    折射率:1.610

    储存条件:-20℃

    蒸汽压:0.0±2.1mmHgat25°C

    展开

    G蛋白偶联受体&G蛋白1415562-82-1
    TargetMol 化合物PF543 PF-543 现货

     6652.00
    T6085 99.02%
    G蛋白偶联受体&G蛋白196597-26-9

    CAS号:196597-26-9

    品名:雷美替胺N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide

    中文别名:雷美尔通;(S)-N-[2-(1,6,7,8-四氢-2H-茚并[5,4-b]呋喃-8-基)乙基]丙酰胺;

    英文别名:UNII-901AS54I69;Rozerem(TN);Rozerem;Ramelteon;Ramelteon[USAN];Rozerem(TM);[14C]-Ramelteon;(S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]propionamide;TAK-375;

    分子式:C16H21NO2

    分子量:259.343

    精确质量:259.157

    Psa:38.33

    MDL号:MFCD08067736

    外观与性状:结晶固体

    密度:1.119g/cm3

    沸点:455.3ºC at 760 mmHg

    熔点:113-115ºC

    闪点:229.2ºC

    折射率:1.555

    蒸汽压:1.77E-08mmHg at 25°C

    简介:Ramelteon,marketedasRozerembyTakedaPharmaceuticalsNorthAmerica,isasleepagentthatselectivelybindstotheMT1andMT2receptorsinthesuprachiasmaticnucleus(SCN),insteadofbindingtoGABAAreceptors,suchaswithdrugslikezolpidem.

     196597-26-9 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:196597-26-9

    品名:雷美替胺N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide

    中文别名:雷美尔通;(S)-N-[2-(1,6,7,8-四氢-2H-茚并[5,4-b]呋喃-8-基)乙基]丙酰胺;

    英文别名:UNII-901AS54I69;Rozerem(TN);Rozerem;Ramelteon;Ramelteon[USAN];Rozerem(TM);[14C]-Ramelteon;(S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]propionamide;TAK-375;

    分子式:C16H21NO2

    分子量:259.343

    精确质量:259.157

    Psa:38.33

    MDL号:MFCD08067736

    外观与性状:结晶固体

    密度:1.119g/cm3

    沸点:455.3ºC at 760 mmHg

    熔点:113-115ºC

    闪点:229.2ºC

    折射率:1.555

    蒸汽压:1.77E-08mmHg at 25°C

    简介:Ramelteon,marketedasRozerembyTakedaPharmaceuticalsNorthAmerica,isasleepagentthatselectivelybindstotheMT1andMT2receptorsinthesuprachiasmaticnucleus(SCN),insteadofbindingtoGABAAreceptors,suchaswithdrugslikezolpidem.

    展开

    G蛋白偶联受体&G蛋白196597-26-9
    TargetMol 雷美替胺 Ramelteon 现货

     6170.00
    T1463 99.92%
    G蛋白偶联受体&G蛋白99755-59-6

    CAS号:99755-59-6

    品名:罗替戈汀[14C]-Rotigotine

    中文别名:(S)-5,6,7,8-四氢-6-(丙基(2-(2-噻吩基)乙基)氨基)-1-萘酚;

    英文别名:(S)-5,6,7,8-TETRAHYDRO-6-(PROPYL(2-(2-THIENYL)ETHYL)AMINO)-1-NAPHTHOL;Rotigotinehydrochloride;Rotigotine;ROTIGOTINE;

    分子式:C19H25NOS

    分子量:315.473

    精确质量:315.166

    Psa:51.71

    UNII号:87T4T8BO2E

    密度:

    海关编码:2934999090

    简介:Rotigotine(Neupro)isadopamineagonistofthenon-ergolineclassofmedicationsindicatedforthetreatmentofParkinson'sdisease(PD)andrestlesslegssyndrome(RLS).Itisformulatedasaonce-dailytransdermalpatchwhichprovidesaslowandconstantsupplyofthedrugoverthecourseof24hours.

     99755-59-6 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:99755-59-6

    品名:罗替戈汀[14C]-Rotigotine

    中文别名:(S)-5,6,7,8-四氢-6-(丙基(2-(2-噻吩基)乙基)氨基)-1-萘酚;

    英文别名:(S)-5,6,7,8-TETRAHYDRO-6-(PROPYL(2-(2-THIENYL)ETHYL)AMINO)-1-NAPHTHOL;Rotigotinehydrochloride;Rotigotine;ROTIGOTINE;

    分子式:C19H25NOS

    分子量:315.473

    精确质量:315.166

    Psa:51.71

    UNII号:87T4T8BO2E

    密度:

    海关编码:2934999090

    简介:Rotigotine(Neupro)isadopamineagonistofthenon-ergolineclassofmedicationsindicatedforthetreatmentofParkinson'sdisease(PD)andrestlesslegssyndrome(RLS).Itisformulatedasaonce-dailytransdermalpatchwhichprovidesaslowandconstantsupplyofthedrugoverthecourseof24hours.

    展开

    G蛋白偶联受体&G蛋白99755-59-6
    TargetMol 罗替戈汀 Rotigotine- 现货

     7220.00
    T6647 99.76%
    G蛋白偶联受体&G蛋白701977-09-5

    CAS号:701977-09-5

    品名:泰伦那班Taranabant

    中文别名:N-[(1S,2S)-3-(4-氯苯基)-2-(3-氰基苯基)-1-甲基丙基]-2-甲基-2-[(5-(三氟甲基)吡啶-2-基)氧基]丙酰胺;

    英文别名:MK0364;2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-Methylpropyl]-2-Methyl-2-[[5-(trifluoroMethyl)-2-pyridinyl]oxy];N-(3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide;Tranabant;Taranabant[usan];N-((2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl)-2-Methyl-2-(pyridin-2-yloxy)propanaMide;N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[(5-(trifluoromethyl)pyridin-2-yl)oxy]propanamide;N-[1S,2S]-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[(5-trifluoromethyl)pyridine-2-yl]oxy}propanamide;

    分子式:C27H25ClF3N3O2

    分子量:515.955

    精确质量:515.159

    Psa:75.01

    UNII号:X9U622S114

    密度:1.3

    沸点:634.2ºC at 760 mmHg

     701977-09-5 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:701977-09-5

    品名:泰伦那班Taranabant

    中文别名:N-[(1S,2S)-3-(4-氯苯基)-2-(3-氰基苯基)-1-甲基丙基]-2-甲基-2-[(5-(三氟甲基)吡啶-2-基)氧基]丙酰胺;

    英文别名:MK0364;2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-Methylpropyl]-2-Methyl-2-[[5-(trifluoroMethyl)-2-pyridinyl]oxy];N-(3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide;Tranabant;Taranabant[usan];N-((2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl)-2-Methyl-2-(pyridin-2-yloxy)propanaMide;N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[(5-(trifluoromethyl)pyridin-2-yl)oxy]propanamide;N-[1S,2S]-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[(5-trifluoromethyl)pyridine-2-yl]oxy}propanamide;

    分子式:C27H25ClF3N3O2

    分子量:515.955

    精确质量:515.159

    Psa:75.01

    UNII号:X9U622S114

    密度:1.3

    沸点:634.2ºC at 760 mmHg

    展开

    G蛋白偶联受体&G蛋白701977-09-5
    源叶 Taranabant Taranabant 期货,请咨询

     5500.00
    S86270 99%
    G蛋白偶联受体&G蛋白120443-16-5

    CAS号:120443-16-5

    品名:维鲁司特3-[(R)-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-[3-(dimethylamino)-3-oxopropyl]sulfanylmethyl]sulfanylpropanoicacid

    中文别名:维鲁司特

    英文别名:MK679;Verlukastum;MK-0679;VERLUKAST;

    分子式:C26H27ClN2O3S2

    分子量:515.087

    精确质量:514.115

    Psa:121.1

    UNII号:5Q9O54P0H7

    密度:1.327g/cm3

    沸点:712.3ºC at 760mmHg

    闪点:384.6ºC

    简介:Areceptorantagonistforthetreatmentofrespiratorydiseases.

     120443-16-5 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:120443-16-5

    品名:维鲁司特3-[(R)-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-[3-(dimethylamino)-3-oxopropyl]sulfanylmethyl]sulfanylpropanoicacid

    中文别名:维鲁司特

    英文别名:MK679;Verlukastum;MK-0679;VERLUKAST;

    分子式:C26H27ClN2O3S2

    分子量:515.087

    精确质量:514.115

    Psa:121.1

    UNII号:5Q9O54P0H7

    密度:1.327g/cm3

    沸点:712.3ºC at 760mmHg

    闪点:384.6ºC

    简介:Areceptorantagonistforthetreatmentofrespiratorydiseases.

    展开

    G蛋白偶联受体&G蛋白120443-16-5
    TRC Verlukast Verlukast 期货,请咨询

     6600.00
    V128500 >95%
    G蛋白偶联受体&G蛋白162760-96-5

    CAS号:162760-96-5

    品名:N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶基-环己烷羧胺N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide

    中文别名:N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶基-环己烷羧胺

    英文别名:Lopac-W-108;N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamidemaleate;cyclohexanecarboxamide,n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl;N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclo-hexanecarboxamide;N-{2-[4-(methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)-cyclohexanecarboxamide;

    分子式:C25H34N4O2

    分子量:422.563

    精确质量:422.268

    Psa:48.91

    UNII号:71IH826FEG

    密度:

    储存条件:-20°C

     162760-96-5 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:162760-96-5

    品名:N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶基-环己烷羧胺N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide

    中文别名:N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶基-环己烷羧胺

    英文别名:Lopac-W-108;N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamidemaleate;cyclohexanecarboxamide,n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl;N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclo-hexanecarboxamide;N-{2-[4-(methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)-cyclohexanecarboxamide;

    分子式:C25H34N4O2

    分子量:422.563

    精确质量:422.268

    Psa:48.91

    UNII号:71IH826FEG

    密度:

    储存条件:-20°C

    展开

    G蛋白偶联受体&G蛋白162760-96-5
    Am WAY-100635 WAY-100635 现货

     6831.00
    A138712 98%
    G蛋白偶联受体&G蛋白290815-26-8

    CAS号:290815-26-8

    品名:N-[6-甲氧基-5-(2-甲氧基苯氧基)-2-(4-吡啶基)-4-嘧啶基]-5-甲基吡啶-2-磺酰胺N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide

    中文别名:N-[6-甲氧基-5-(2-甲氧基苯氧基)-2-(4-吡啶基)-4-嘧啶基]-5-甲基吡啶-2-磺酰胺

    英文别名:Avosentan;SPP301;Ro67-0565;UNII-L94KSX715K;

    分子式:C23H21N5O5S

    分子量:479.508

    精确质量:479.126

    Psa:133.8

    密度:1.364 g/cm3

    沸点:575.472ºC at 760 mmHg

    闪点:301.835ºC

    简介:AvosentanisacompetitiveantagonistofEndothelin-1(ET-1)withahighselectivityfortheETAreceptor.Avosentanmaybeapotentialoptioninthetreatmentofglaucoma.

     290815-26-8 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:290815-26-8

    品名:N-[6-甲氧基-5-(2-甲氧基苯氧基)-2-(4-吡啶基)-4-嘧啶基]-5-甲基吡啶-2-磺酰胺N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide

    中文别名:N-[6-甲氧基-5-(2-甲氧基苯氧基)-2-(4-吡啶基)-4-嘧啶基]-5-甲基吡啶-2-磺酰胺

    英文别名:Avosentan;SPP301;Ro67-0565;UNII-L94KSX715K;

    分子式:C23H21N5O5S

    分子量:479.508

    精确质量:479.126

    Psa:133.8

    密度:1.364 g/cm3

    沸点:575.472ºC at 760 mmHg

    闪点:301.835ºC

    简介:AvosentanisacompetitiveantagonistofEndothelin-1(ET-1)withahighselectivityfortheETAreceptor.Avosentanmaybeapotentialoptioninthetreatmentofglaucoma.

    展开

    G蛋白偶联受体&G蛋白290815-26-8
    源叶 Avosentan Avosentan 期货,请咨询

     5800.00
    S84798 98%
    G蛋白偶联受体&G蛋白558447-26-0

    CAS号:558447-26-0

    品名:N’-(1H-苯并咪唑-2-甲基)-N’-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

    中文别名:N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺;N`-(1H-苯并咪唑-2-甲基)-N`-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺;

    英文别名:N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine;

    分子式:C21H27N5

    分子量:349.473

    精确质量:349.227

    Psa:70.83

    MDL号:MFCD11977316

    密度:1.21

    熔点:108-110ºC

    海关编码:2933990090

     558447-26-0 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:558447-26-0

    品名:N’-(1H-苯并咪唑-2-甲基)-N’-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

    中文别名:N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺;N`-(1H-苯并咪唑-2-甲基)-N`-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺;

    英文别名:N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine;

    分子式:C21H27N5

    分子量:349.473

    精确质量:349.227

    Psa:70.83

    MDL号:MFCD11977316

    密度:1.21

    熔点:108-110ºC

    海关编码:2933990090

    展开

    G蛋白偶联受体&G蛋白558447-26-0
    源叶 AMD-070 (S)-N1-((1H-benzo[d]imidazol... 期货,请咨询

     6400.00
    Y39077 ≥99%
    G蛋白偶联受体&G蛋白183232-66-8

    CAS号:183232-66-8

    品名:1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-1-哌啶基-1H-吡唑-3-羧胺1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide

    中文别名:1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-(哌啶-1-基)-1H-吡唑-3-甲酰胺;

    英文别名:1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide;Tocris-1117;AM251;

    分子式:C22H21Cl2IN4O

    分子量:555.239

    精确质量:554.014

    Psa:50.16

    MDL号:MFCD01861181

    外观与性状:一种结晶固体

    密度:1.65 g/cm3

    折射率:1.702

    安全说明:S26; S36

    危险类别码:R36/37/38

    危险品标志:Xi

    信号词:Warning

    危险性防范说明:P261; P305 + P351 + P338

    危险标志:GHS07

    危险性描述:H315; H319; H335

    简介:InhibitorofCB1receptors.AM251isabiarylpyrazolecompoundwhichhasbeenconsideredformanyyearsastheprototypicalcannabinoid(CB)receptorantagonist

     183232-66-8 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:183232-66-8

    品名:1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-1-哌啶基-1H-吡唑-3-羧胺1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide

    中文别名:1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-(哌啶-1-基)-1H-吡唑-3-甲酰胺;

    英文别名:1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide;Tocris-1117;AM251;

    分子式:C22H21Cl2IN4O

    分子量:555.239

    精确质量:554.014

    Psa:50.16

    MDL号:MFCD01861181

    外观与性状:一种结晶固体

    密度:1.65 g/cm3

    折射率:1.702

    安全说明:S26; S36

    危险类别码:R36/37/38

    危险品标志:Xi

    信号词:Warning

    危险性防范说明:P261; P305 + P351 + P338

    危险标志:GHS07

    危险性描述:H315; H319; H335

    简介:InhibitorofCB1receptors.AM251isabiarylpyrazolecompoundwhichhasbeenconsideredformanyyearsastheprototypicalcannabinoid(CB)receptorantagonist

    展开

    G蛋白偶联受体&G蛋白183232-66-8
    罗恩 AM251 AM251 5~7个工作日

     5339.00
    R029276 98%
    G蛋白偶联受体&G蛋白929622-08-2

    CAS号:929622-08-2

    品名:(4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone

    中文别名:(4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone

    英文别名:(4-cyclopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone;UNII-9827P7LFVH;BAVISANT;Bavisant[USAN:INN];

    分子式:C19H27N3O2

    分子量:329.437

    精确质量:329.21

    Psa:36.02

    密度:

    储存条件:2-8℃

     929622-08-2 详细信息

    G蛋白偶联受体&G蛋白

    CAS号:929622-08-2

    品名:(4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone

    中文别名:(4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone

    英文别名:(4-cyclopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone;UNII-9827P7LFVH;BAVISANT;Bavisant[USAN:INN];

    分子式:C19H27N3O2

    分子量:329.437

    精确质量:329.21

    Psa:36.02

    密度:

    储存条件:2-8℃

    展开

    G蛋白偶联受体&G蛋白929622-08-2
    毕得 (4-环丙基哌嗪-1-基)(4-(吗啉甲基)苯基)甲酮 (4-Cyclopropylpiperazin-1-yl... 现货

     5382.00
    BD631025 99%
温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算
微信 ×

打开微信,点击底部的“发现”

使用“扫一扫”即可将网页分享至朋友圈